FLASH Study: Clinical Trial Update

The Cutaneous Lymphoma Foundation's CEO Susan Thornton spoke with Dr. Ellen Kim about clinical trials, and specifically the FLASH [Fluorescent Light Activated Synthetic Hypericin] Study. FLASH is a potential new treatment for early stage cutaneous lymphoma using visible fluorescent light. Dr. Kim is a professor of dermatology at the University of Pennsylvania and a cutaneous lymphoma specialist.

Read more about the FLASH clinical trial.